These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 26912815)
21. Identification of novel allosteric modulator binding sites in NMDA receptors: A molecular modeling study. Kane LT; Costa BM J Mol Graph Model; 2015 Sep; 61():204-13. PubMed ID: 26280688 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro characterisation of ifenprodil-based fluorescein conjugates as GluN1/GluN2B N-Methyl-D-aspartate receptor antagonists. Dhilly M; Becerril-Ortega J; Colloc'h N; MacKenzie ET; Barré L; Buisson A; Nicole O; Perrio C Chembiochem; 2013 Apr; 14(6):759-69. PubMed ID: 23532918 [TBL] [Abstract][Full Text] [Related]
23. Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors. Hansen KB; Ogden KK; Yuan H; Traynelis SF Neuron; 2014 Mar; 81(5):1084-1096. PubMed ID: 24607230 [TBL] [Abstract][Full Text] [Related]
24. Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold. Dey S; Schepmann D; Wünsch B Bioorg Med Chem Lett; 2016 Feb; 26(3):889-893. PubMed ID: 26750254 [TBL] [Abstract][Full Text] [Related]
25. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors. Mullier B; Wolff C; Sands ZA; Ghisdal P; Muglia P; Kaminski RM; André VM Neuropharmacology; 2017 Sep; 123():322-331. PubMed ID: 28533163 [TBL] [Abstract][Full Text] [Related]
26. Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines. Mony L; Zhu S; Carvalho S; Paoletti P EMBO J; 2011 Jun; 30(15):3134-46. PubMed ID: 21685875 [TBL] [Abstract][Full Text] [Related]
27. Exploring neuroprotective potential of Withania somnifera phytochemicals by inhibition of GluN2B-containing NMDA receptors: An in silico study. Kumar G; Patnaik R Med Hypotheses; 2016 Jul; 92():35-43. PubMed ID: 27241252 [TBL] [Abstract][Full Text] [Related]
30. On mechanism of allosteric modulation of NMDA receptor via amino-terminal domains. Karlov DS; Radchenko EV; Zefirov AN; Palyulin VA; Pentkovski VM; Zefirov NS Biochem Biophys Res Commun; 2012 Aug; 424(4):687-90. PubMed ID: 22789854 [TBL] [Abstract][Full Text] [Related]
31. Replacement of the Benzylpiperidine Moiety with Fluorinated Phenylalkyl Side Chains for the Development of GluN2B Receptor Ligands. Thum S; Schepmann D; Kalinin DV; Ametamey SM; Wünsch B ChemMedChem; 2018 Dec; 13(23):2522-2529. PubMed ID: 30312542 [TBL] [Abstract][Full Text] [Related]
32. Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function. Hackos DH; Lupardus PJ; Grand T; Chen Y; Wang TM; Reynen P; Gustafson A; Wallweber HJ; Volgraf M; Sellers BD; Schwarz JB; Paoletti P; Sheng M; Zhou Q; Hanson JE Neuron; 2016 Mar; 89(5):983-99. PubMed ID: 26875626 [TBL] [Abstract][Full Text] [Related]
33. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits. Coughenour LL; Barr BM J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375 [TBL] [Abstract][Full Text] [Related]
34. 2-Methyltetrahydro-3-benzazepin-1-ols - The missing link in SAR of GluN2B selective NMDA receptor antagonists. Dey S; Schepmann D; Wünsch B Bioorg Med Chem; 2018 Jan; 26(2):501-508. PubMed ID: 29254894 [TBL] [Abstract][Full Text] [Related]
35. Negative allosteric modulators of the GluN2B NMDA receptor with phenylethylamine structure embedded in ring-expanded and ring-contracted scaffolds. Temme L; Bechthold E; Schreiber JA; Gawaskar S; Schepmann D; Robaa D; Sippl W; Seebohm G; Wünsch B Eur J Med Chem; 2020 Mar; 190():112138. PubMed ID: 32070917 [TBL] [Abstract][Full Text] [Related]